Replimune Group (REPL) PT Raised to $40 at BMO Capital Ahead of RP1 Data
Tweet Send to a Friend
BMO Capital analyst Evan Seigerman raised the price target on Replimune Group (NASDAQ: REPL) to $40.00 (from $30.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
